Advertisement第120回日本精神神経学会学術総会

Abstract

第125巻第12号

※会員以外の方で全文の閲覧をご希望される場合は、「電子書籍」にてご購入いただけます。
Therapeutic Strategies for Somatic Symptom Disorders: Tailored Interventions in Intractable Cases
Yasuhide NAGOSHI1, Toshiyuki TOMINAGA2, Mie SAKAI3,4, Ayumu TATENO5
1 Department of Psychiatry (Psychosomatic Medicine), Japanese Red Cross Kyoto Daiichi Hospital
2 Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
3 Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences
4 Pain Center, Nagoya City University Hospital
5 Department of Psychiatry, The Jikei University School of Medicine
Psychiatria et Neurologia Japonica 125: 1010-1022, 2023
https://doi.org/10.57369/pnj.23-145
Accepted in revised form: 29 July 2023.

 We should provide tailor-made treatment for patients with intractable somatic symptom disorders (SSDs). For example, it would be ideal to select the best treatment method that fits each patient, modify it according to their condition, and even use a multidimensional approach when necessary.
 In pharmacotherapy, it is often necessary to use elaborate regimens such as augmentation therapy. Additionally, we should pay careful attention to nocebo responses.
 In cognitive behavioral therapy (CBT), we must carefully decide on the frequency, length, content, and type (i. e., individual or group) of sessions to improve treatment adherence.
 Unlike the traditional medical model, the goal of acceptance and commitment therapy (ACT) and Morita therapy is not to achieve symptom resolution, but rather to promote behavioral changes. Both therapies are appropriate for patients with intractable SSDs.
 Authors' abstract

Keywords:somatic symptom disorder, pharmacotherapy, cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), Morita therapy>
Advertisement

ページの先頭へ

Copyright © The Japanese Society of Psychiatry and Neurology